These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34753182)

  • 1. Determinant of Prenatal Diagnostic Testing among Women with Increased Risk of Fetal Aneuploidy and Genetic Disorders.
    Morgan T; Tan CD; Della-Torre M; Jackson-Bey T; DiGiovanni L; Enakpene CA
    Am J Perinatol; 2024 Mar; 41(4):470-477. PubMed ID: 34753182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).
    ; Prabhu M; Kuller JA; Biggio JR
    Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Preprocedure Genetic Counseling in Pregnancies Interrupted for Fetal Abnormalities.
    Francoeur AA; Kang SL; Senaratne TN; Saitta S; Murali A; Peters K; Hansman E; Chen A; Parvataneni R; Patil R; Rible R; Sridhar A; Stoddard A; Zapata M; Krakow D; Pluym ID
    Am J Perinatol; 2024 Mar; 41(4):383-394. PubMed ID: 38154468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
    Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
    Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of combined detailed first-trimester ultrasound-biochemical analysis for screening fetal aneuploidy in the era of non-invasive prenatal testing.
    Ye C; Duan H; Liu M; Liu J; Xiang J; Yin Y; Zhou Q; Yang D; Yan R; Li R
    Arch Gynecol Obstet; 2024 Aug; 310(2):843-853. PubMed ID: 37938359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for fetal aneuploidy.
    Rink BD; Norton ME
    Semin Perinatol; 2016 Feb; 40(1):35-43. PubMed ID: 26725144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.
    Hui L; Pynaker C; Bonacquisto L; Lindquist A; Poulton A; Kluckow E; Hutchinson B; Norris F; Pertile MD; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
    Am J Obstet Gynecol; 2021 Nov; 225(5):527.e1-527.e12. PubMed ID: 33957116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
    Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
    J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the frequency of soft sonographic aneuploidy markers vary by fetal sex?
    Wax JR; Cartin A; Pinette MG; Blackstone J
    J Ultrasound Med; 2005 Aug; 24(8):1059-63. PubMed ID: 16040819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study.
    Lord J; McMullan DJ; Eberhardt RY; Rinck G; Hamilton SJ; Quinlan-Jones E; Prigmore E; Keelagher R; Best SK; Carey GK; Mellis R; Robart S; Berry IR; Chandler KE; Cilliers D; Cresswell L; Edwards SL; Gardiner C; Henderson A; Holden ST; Homfray T; Lester T; Lewis RA; Newbury-Ecob R; Prescott K; Quarrell OW; Ramsden SC; Roberts E; Tapon D; Tooley MJ; Vasudevan PC; Weber AP; Wellesley DG; Westwood P; White H; Parker M; Williams D; Jenkins L; Scott RH; Kilby MD; Chitty LS; Hurles ME; Maher ER;
    Lancet; 2019 Feb; 393(10173):747-757. PubMed ID: 30712880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
    Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What are the real purpose and scope of screening for aneuploidy?].
    Quibel T; Rozenberg P
    Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socioeconomic disparities in diagnostic testing after positive aneuploidy screening.
    Wong AE; Dungan J; Feinglass J; Grobman WA
    Am J Perinatol; 2015 Feb; 30(2):205-10. PubMed ID: 24936938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
    Chasen ST; McCullough LB; Chervenak FA
    Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.